Mirae Asset Global Investments Co. Ltd. bought a new stake in Cognex Corporation (NASDAQ:CGNX – Free Report) during the third quarter, Holdings Channel.com reports. The firm bought 25,589 shares of the scientific and technical instruments company’s stock, valued at approximately $1,552,000.
Other large investors also recently bought and sold shares of the company. BlackRock Inc. purchased a new position in Cognex during the second quarter worth about $1,158,123,000. Jupiter Topco LLC purchased a new stake in shares of Cognex in the 2nd quarter valued at approximately $161,425,000. Bank of New York Mellon Corp purchased a new stake in shares of Cognex in the 2nd quarter valued at approximately $129,348,000. Front Street Capital Management Inc. acquired a new position in shares of Cognex in the 2nd quarter worth approximately $90,581,000. Finally, Bamco Inc. NY acquired a new position in shares of Cognex in the 2nd quarter worth approximately $90,605,000. Institutional investors and hedge funds own 88.12% of the company’s stock.
More Cognex News
Here are the key news stories impacting Cognex this week:
- Positive Sentiment: Cognex reported record Q3 results, with earnings of $0.53 per share beating estimates and revenue growing year over year. Management raised its 2026 revenue outlook to $1.14 billion–$1.16 billion and cited margin expansion and stronger logistics demand. Q3 earnings call outlook and margin expansion
- Positive Sentiment: The planned RealSense acquisition could add growth opportunities, while management is targeting further margin expansion. Cognex reports record third-quarter results and RealSense acquisition
- Positive Sentiment: The company raised its quarterly dividend by 5.9% to $0.09 per share, a modest signal of confidence in cash generation.
- Negative Sentiment: Several firms cut their price targets: Stephens lowered its target to $70, KeyCorp to $65, Needham to $70, and Truist to $57. The cuts may temper enthusiasm despite the improved outlook; ratings remain mostly overweight or buy, while Truist is at hold. Stephens price-target change
Cognex Stock Performance
Shares of CGNX opened at $47.78 on Friday. The company’s 50-day simple moving average is $59.06 and its 200-day simple moving average is $58.04. Cognex Corporation has a 1 year low of $34.60 and a 1 year high of $72.88. The stock has a market capitalization of $8.04 billion, a PE ratio of 33.41 and a beta of 1.49.
Cognex (NASDAQ:CGNX – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 EPS for the quarter, topping the consensus estimate of $0.52 by $0.01. Cognex had a net margin of 21.50% and a return on equity of 15.75%. The business had revenue of $313.39 million during the quarter, compared to the consensus estimate of $313.62 million. During the same quarter in the previous year, the firm posted $0.33 earnings per share. The company’s quarterly revenue was up 13.0% compared to the same quarter last year. On average, sell-side analysts predict that Cognex Corporation will post 1.70 earnings per share for the current year.
Cognex Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, December 3rd. Shareholders of record on Thursday, November 19th will be issued a dividend of $0.09 per share. This is a positive change from Cognex’s previous quarterly dividend of $0.0850. The ex-dividend date is Thursday, November 19th. This represents a $0.36 annualized dividend and a yield of 0.8%. Cognex’s dividend payout ratio (DPR) is currently 23.78%.
Wall Street Analysts Forecast Growth
A number of equities analysts recently weighed in on CGNX shares. DA Davidson reaffirmed a “neutral” rating and set a $65.00 price objective on shares of Cognex in a research report on Wednesday, September 23rd. Zacks Research lowered Cognex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Barclays upped their price target on Cognex from $80.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday, October 12th. Truist Financial lowered their price target on Cognex from $74.00 to $57.00 and set a “hold” rating for the company in a research report on Friday. Finally, KeyCorp dropped their price objective on Cognex from $80.00 to $65.00 and set an “overweight” rating for the company in a research note on Friday. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat.com, Cognex currently has a consensus rating of “Moderate Buy” and a consensus target price of $72.93.
Read Our Latest Stock Analysis on CGNX
About Cognex
Featured Stories
- Five stocks we like better than Cognex
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
